NO913131L - Immunogene konjugater av ikke-toksisk oligosakkarid fra bordetella pertussis lipoolysakkarid. - Google Patents
Immunogene konjugater av ikke-toksisk oligosakkarid fra bordetella pertussis lipoolysakkarid.Info
- Publication number
- NO913131L NO913131L NO91913131A NO913131A NO913131L NO 913131 L NO913131 L NO 913131L NO 91913131 A NO91913131 A NO 91913131A NO 913131 A NO913131 A NO 913131A NO 913131 L NO913131 L NO 913131L
- Authority
- NO
- Norway
- Prior art keywords
- toxic
- pertussis
- lipoolysaccharide
- oligosaccharide
- tell
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/099—Bordetella
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Abstract
Ikke-toksiske oligosakkarider avledet fra Bordetellaertussis-lipooligosakkarid og konjugater derv, hvori oligo-sakkaridene er bundet til et bærerprotein såsom trådformet hemagglutinin fra Bordetella pertussis. vaksinepreparater som inneholder konjugatene, og fremgangsmåter for fremkalling av immunrespons mot Bordetella pertussis omfattende administrasjon av slike konjugater med en farmasøytisk akseptabel bærer til et varmblodig dyr.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US56516290A | 1990-08-13 | 1990-08-13 |
Publications (2)
Publication Number | Publication Date |
---|---|
NO913131D0 NO913131D0 (no) | 1991-08-12 |
NO913131L true NO913131L (no) | 1992-02-14 |
Family
ID=24257465
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO91913131A NO913131L (no) | 1990-08-13 | 1991-08-12 | Immunogene konjugater av ikke-toksisk oligosakkarid fra bordetella pertussis lipoolysakkarid. |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP0471954A3 (no) |
JP (1) | JPH04230635A (no) |
AU (1) | AU8175691A (no) |
CA (1) | CA2048871A1 (no) |
FI (1) | FI913819A (no) |
IL (1) | IL98716A0 (no) |
NO (1) | NO913131L (no) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0471177B1 (en) * | 1990-08-13 | 1995-10-04 | American Cyanamid Company | Filamentous hemagglutinin of bordetella pertussis as a carrier molecule for conjugate vaccines |
FR2754543B1 (fr) * | 1996-10-11 | 1998-12-31 | Pasteur Institut | Souche de bordetella deficiente dans la production de toxine et exprimant une proteine hydride, liposomes comprenant de la fha et leurs utilisations comme vaccins, et utilisation de la fha pour stimuler les reponses immunitaires |
GB0211118D0 (en) * | 2002-05-15 | 2002-06-26 | Polonelli Luciano | Vaccines |
WO2008013735A2 (en) * | 2006-07-21 | 2008-01-31 | The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services | Methods for conjugation of oligosaccharides or polysaccharides to protein carriers through oxime linkages via 3-deoxy-d-manno-octulsonic acid |
WO2012106251A2 (en) * | 2011-01-31 | 2012-08-09 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Pertussis vaccine |
PL404247A1 (pl) | 2013-06-07 | 2014-12-08 | Wrocławskie Centrum Badań Eit + Spółka Z Ograniczoną Odpowiedzialnością | Koniugat oligocukru LOS Bordetella pertussis i toksyny krztuśca i jego zastosowanie w profilaktyce i leczeniu zakażeń wywoływanych przez Bordetella pertussis |
JP2018513218A (ja) | 2015-04-16 | 2018-05-24 | インベントプライズ リミテッド ライアビリティ カンパニー | 百日咳菌免疫原性ワクチン組成物 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4474758A (en) * | 1981-11-19 | 1984-10-02 | American Cyanamid Company | Haemophilus influenzae type b and pertussis outer membrane component combined vaccine |
US4761283A (en) * | 1983-07-05 | 1988-08-02 | The University Of Rochester | Immunogenic conjugates |
GB8512972D0 (en) * | 1985-05-22 | 1985-06-26 | Univ Glasgow | Vaccine production |
EP0471177B1 (en) * | 1990-08-13 | 1995-10-04 | American Cyanamid Company | Filamentous hemagglutinin of bordetella pertussis as a carrier molecule for conjugate vaccines |
-
1991
- 1991-07-01 EP EP19910110851 patent/EP0471954A3/en not_active Withdrawn
- 1991-07-02 IL IL98716A patent/IL98716A0/xx unknown
- 1991-08-08 JP JP3222381A patent/JPH04230635A/ja active Pending
- 1991-08-09 AU AU81756/91A patent/AU8175691A/en not_active Abandoned
- 1991-08-09 CA CA002048871A patent/CA2048871A1/en not_active Abandoned
- 1991-08-12 FI FI913819A patent/FI913819A/fi not_active Application Discontinuation
- 1991-08-12 NO NO91913131A patent/NO913131L/no unknown
Also Published As
Publication number | Publication date |
---|---|
FI913819A (fi) | 1992-02-14 |
CA2048871A1 (en) | 1992-02-14 |
AU8175691A (en) | 1992-02-20 |
EP0471954A3 (en) | 1993-03-03 |
JPH04230635A (ja) | 1992-08-19 |
NO913131D0 (no) | 1991-08-12 |
IL98716A0 (en) | 1992-07-15 |
FI913819A0 (fi) | 1991-08-12 |
EP0471954A2 (en) | 1992-02-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1170016A3 (en) | Urease-based vaccine against helicobacter infection | |
NO306905B1 (no) | Oligosakkarid avledet fra antigent polysakkarid erholdt fra et patogen | |
EP0528859A4 (en) | Oral vaccine comprising antigen surface-associated with red blood cells | |
NZ291262A (en) | E. coli heat-labile enterotoxin derivatives and their use as oral adjuvants | |
PL307745A1 (en) | Vaccines against neisseria meningitidis of c group | |
DK0427347T3 (da) | Syntetiske peptider, der kan anvendes som universelle bærere til fremstilling af immunogene konjugater, og anvendelse deraf til udvikling af syntetiske vacciner | |
DK1187629T3 (da) | Adjuvanssammensætning omfattende saponin og et immunostimulerende oligonucleotid | |
NO920350D0 (no) | Konjugat av pneumokokkpolysakkarid og immunogent protein,fremgangsmaate for fremstilling av konjugatet, samt vaksine som inneholder konjugatet | |
ES465514A1 (es) | Procedimiento para la obtencion de derivados de glucosamina. | |
NO975366D0 (no) | Vaksine sammensetning inneholdende polyribosylribitol fosfat og fremgangsmåte for fremstilling derav | |
ES8608883A1 (es) | Procedimiento de preparacion de un conjugado de muramilpeptido y de un hapteno o fragmento haptenico de bajo peso molecular. | |
NO913131L (no) | Immunogene konjugater av ikke-toksisk oligosakkarid fra bordetella pertussis lipoolysakkarid. | |
EP0090660A3 (en) | Neisseria gonorrhoeae vaccine | |
FI971402A0 (fi) | Menetelmä voimistettujen antigeenisten Helico-bacter-lajien ja niitä sisältävien rokotteiden valmistamiseksi | |
CA2133108A1 (en) | Pasteurella haemolytica type a-1 bacterin-toxoid vaccine | |
AU8501191A (en) | Cross-reactive influenza a immunization | |
RU93005000A (ru) | Композиция вакцин, способ ее получения, способ исключения иммунной реакции |